When data acquisition is configured to acquire using “Averaging”, some signal amplitude excursions may need to be excluded during the averaging process. Artifact Rejection, available via a checkbox in the averaging setup, is a feature for just this purpose.
To perform on-line averaging, first choose “MP150 > Set Up Acquisition…” (older versions of AcqKnowledge) or “MP150 > Set Up Data Acquisition…” and choose “Length/Rate” in the pane on the left (AcqKnowledge version 4.4). In the top row of pulldown menus, choose “Record” and “Save one” using “Averaging”. Underneath “Averaging”, a “Setup” button will be enabled. Click that button to set up various aspects of averaging (e.g., the number of trials) and click the “Artifact rejection” checkbox.
When artifact rejection is enabled this way, the MP150 System will ignore any trials that contain signals exceeding the artifact rejection thresholds, keep track of how many trials have been rejected, and add that number of trials to the total number of trials to be acquired. This allows users to “re-try” a trial that was rejected due to the presence of artifact.
Workflow—A Great Tool for Every Researcher! Automate AcqKnowledge with New Workflow Tool New automation tool significantly saves time and improves consistency with standardized procedures Workflow’s drag-and-drop interface allows you to automate and repeat the signal-conditioning and processing steps your protocol requires in an easy-to-use process without programming or scripting knowledge. Batch process multiple files with confidence […]
The mind and body work together in many ways and psychophysiology research provides insight to these connections. BIOPAC has a variety of systems to power your emotion, arousal, stress, cognitive assessment, group interaction, startle, and other psychophysiology research. Here are some recent studies that have used BIOPAC systems for psychophysiological research… Skin conductance, facial EMG, […]
For immediate release: January 4, 2023 Amiens, France and GOLETA, California, USA Seenel Imaging SAS and BIOPAC Systems, Inc. have formed a long-term global partnership to distribute MedelOpt®, Seenel Imaging’s groundbreaking wearable neuroimaging device for the neuroscience research market. Seenel Imaging, based in France, continues its international expansion by partnering with BIOPAC Systems, […]